DR Horton earnings missed by $0.34, revenue topped estimates
DR Horton (DHI) reported Q4 EPS of $2.67, missing estimates by $0.34, while revenue of $9.4B exceeded expectations. The stock is down 0.04% over 3 months and 4.21% over 12 months. InvestingPro rates its financial health as 'good performance'.
How this was made
The 30-second read
Why it matters
The earnings miss may trigger short‑term sell pressure, while the revenue beat offers a modest upside narrative.
Market read
First‑time disclosure of earnings miss for a large‑cap builder; relevant for traders targeting housing sector moves.
What to watch
Guidance outlook and macro housing demand data were not provided.
Background
DR Horton is a leading U.S. homebuilder; its quarterly earnings are closely watched by housing sector investors.
Ticker impact
DR Horton reported Q4 EPS of $2.67, missing estimates by $0.34 and revenue of $9.4B beating forecasts.
likely pressure as the market prices in the EPS miss
The EPS shortfall is material for a large‑cap homebuilder and was disclosed for the first time.
Market effects
Homebuilding sector may see broader sentiment impact from the miss.
U.S. housing‑related stocks could face short‑term pressure.
Limited to U.S. equity markets.
Counterpoint
Revenue beat could offset EPS miss if investors focus on top‑line strength.
Key entities
- CompanyDR Horton
U.S. homebuilder reporting Q4 results.




